DOPATREE
Preview
Open in TheBrain
DOPATREE
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
GASTROINTESTINAL CONDITIONS-ALL (GI, DIGESTIVE DISEASES, GASTROENTEROLOGY, GASTRIC, INTESTINAL)
GASTROINTESTINAL CONDITIONS / LISTINGS
NONALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS (NAFLD, NASH, NON-ALCOHOLIC, HEPATIC STEATOSIS, FLD, NONCIRRHOTIC)
NASH / MARKET ACCESS
Parents
NONALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS (NAFLD, NASH, NON-ALCOHOLIC, HEPATIC STEATOSIS, FLD, NONCIRRHOTIC)
Children
ICER. NON-ALCOHOLIC STEATOHEPATITIS. AN ASSESSMENT OF RESMETIROM AND OBETICHOLIC ACID FOR NASH. PUBLIC MEETING : APR 2023.
ICER. PRIMARY BILIARY COLANGITIS AND NON-ALCOHOLIC STEATOHEPATITIS. PUBLIC MTG. JUL 2016.